SRPT: Sarepta Therapeutics, Inc.
Performance
SRPT -2.21%
Watchlist
Select an item
Summary
SRPT at a glance
SRPT returned -2.21% over the past year and -27.91% a year over five years. Its worst drop in that year was -37.64%, smaller than 42% of stocks on Redstone, and its Sharpe ratio of 0.25 beats 39% of stocks on Redstone. It pays no dividends.
Current Drawdown
-27.65%
Rolling Volatility
60.63%
Actions
Metrics
Risk Indicators
Alpha1.44%
Beta1.67x
Sharpe0.25
Sortino0.41
Omega1.05
Calmar-0.06
Martin0.85
Profile
About SRPT
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.8B
- Listed
- Jun 1997
- Employees
- 835
- Headquarters
- Cambridge, MA
- Website
- sarepta.com
Comparisons